02:35 AM EDT, 10/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target price of $155, valuing GL shares at 9.6x our newly initiated 2027 operating EPS estimate of $16.20 and at 10.3x our 2026 EPS estimate of $15.00 (lowered by $0.50). This compares with GL's five-year average forward multiple of 10.6x and the peer average of 9x. We raise our 2025 EPS estimate by $0.05, to $14.50. GL posted Q3 EPS of $4.81 versus $3.49 in the prior year, beating our $3.95 estimate and the $4.54 consensus view. Operating revenue grew 4%, with life insurance premiums rising 3% and health premiums up 9%, while underwriting income surged 30%, supported by a 10 percentage point rise in life underwriting margins to 57% and a 3 percentage point rise in health margins to 28%. We expect share buybacks to continue supporting per-share results, as GL repurchased 840K shares for $113M in Q3. We also view the favorable conclusion of the DOJ and SEC investigations as a positive catalyst for the shares.